The global sales of infusion pump is estimated to be worth USD 4,932.2 million in 2024 and anticipated to reach a value of USD 8,345.4 million by 2034. Sales are projected to rise at a CAGR of 5.4% over the forecast period between 2024 and 2034. The revenue generated by infusion pump cover in 2023 was USD 4,688.2 million. The industry is anticipated to exhibit a Y-o-Y growth of 5.2% in 2024.
Infusion pumps are devices used in healthcare settings to administer fluids into patients' bodies. It assist in administration of medications, nutrients, and fluids for hydration in a controlled fashion, which means in exact quantities and at designated speeds over a specified duration.
It is commonly administered through a vein, and occasionally it may also be administered under the skin, or in artery and spinal infusions.
They usually vary in complexity and features and ranges from simple gravity-driven devices to sophisticated electronic pumps capable of programming complex infusion protocols.
The continuously evolving advancements in medical devices to meet the growing demand of healthcare industry propels the growth of the market.
Global Infusion Pumps Industry Assessment
| Attributes | Key Insights |
|---|---|
| Historical Size, 2023 | USD 4,688.2 million |
| Estimated Size, 2024 | USD 4,932.2 million |
| Projected Size, 2034 | USD 8,345.4 million |
| Value-based CAGR (2024 to 2034) | 5.2% |
Infusion pumps have an important role in the hospitals, clinics, and healthcare facilities. They assist clinicians to administer precise amount of medication to patients. They ensures correct dosage of drugs are administered intravenously to the patients at for critical care.
It also supports patients who are unable to have their food by mouth as it delivers it directly into the blood stream. During procedures it is used for the maintaining the body fluid levels of the patients. In oncology, infusion pumps permit infusion of chemotherapy drugs at very precise rates, optimizing treatment outcomes.
The infusion pump cover market is set to experience a significant growth of 5.4% during the forecast period. It is projected to create an incremental opportunity of USD 3,413.2 million and is predicted to rise 1.7 times the current market value through 2034.
Advancement in technology with regard to accuracy and other safety features for the accurate delivery of medications in healthcare paves the way for the market growth of infusion pumps. The rising cases of chronic diseases that require long-term therapies and the senile population raise demand for infusion pumps in managing complicated medical conditions.
Growth in healthcare facilities and fast-growing trends in home healthcare further fuel the market growth by demanding portable and user-friendly designs in pumps. Moreover, their critical role in pain management and anesthesia for various therapeutic treatments makes them important not only across all hospital settings but also in outpatient care. This is further bolstered by government initiatives that drive spending in the development of healthcare infrastructure.
Explore FMI!
Book a free demo
The table below compares the Compound Annual Growth Rate (CAGR) for the global infusion pump market from 2023 to 2024 during the first half of the year. This overview highlights key changes and trends in revenue growth, offering valuable insights into market dynamics. H1 covers January to June, while H2 spans July to December.
| Particular | Value CAGR |
|---|---|
| H1 | 6.4% (2023 to 2033) |
| H2 | 6.0% (2023 to 2033) |
| H1 | 5.4% (2024 to 2034) |
| H2 | 4.9% (2024 to 2034) |
In the first half (H1) of the decade from 2023 to 2033, the business is predicted to surge at a CAGR of 6.4%, followed by a slightly decline in growth rate of 6% in the second half (H2) of the same decade.
Moving into the subsequent period, from H1 2024 to H2 2034, the CAGR is projected to increase slightly to 5.4% in the first half and remain relatively moderate at 4.9% in the second half. In the first half (H1) the market witnessed a decrease of 100 BPS while in the second half (H2), the market witnessed a decrease of 110 BPS.
Rising Prevalence of Various Disease is Augmenting its Growth in the Hospital
The growing prevalence of chronic diseases, like diabetes, hypertension, and cardiovascular disorders, is supporting the market growth. Since chronic patients are dependent on medication therapy for a greater period, the requirement for accurate and safe infusion pumps is increasing.
Since infusion pumps provide medicaments at a controlled rate, there are reduced chances of side effects of the medicament, and the treatment outcome gets improved.
There is also a trend toward home healthcare, where patients prefer to get treated in relatively familiar surroundings. With infusion pumps, it is now possible to deliver medicines to a patient out of a healthcare institute, providing medication effectively and safely while supporting the growing trend of patient-centered care.
Therefore, these pumps have turned into an essentiality for providing continuous treatment to patients either in a hospital setup or through the current fast-growing trend of home-based infusion therapies. Thereby, demand for infusion pumps is further boosted by the ever-growing treatment of chronic diseases.
Technological Advancements in the Infusion Pumps is Driving the Market Growth
Infusion pumps have undergone tremendous transformation, which has revolutionized their applicability and acceptance into healthcare services.
These innovations have primarily enhanced the infusion accuracy by incorporating improved delivery modes to promote the dispensing of the correct drug dose required for managing complex life conditions such as cancer, diabetes, and pain management.
The enhancement in the safety features of these devices with pumps being fitted with alarm systems and sensors to identify problems like air bubbles or occlusion, reduces the accidental risks and promotes patient safety.
Besides that, introduction of infusion pumps with new designs and advanced software have made these pumps more portable, user-friendly, and durable for hospital setting and home healthcare. For instance, in August 2023, ICU Medical Inc., a company engaged in the manufacturing and sale of innovative medical devices received FDA clearance for its new Plum Duo infusion pump.
These new infusion pump is built on the precise delivery of the unique cassette technology. Therefore, growing emphasis of manufacturers on inclusion of new of software’s and technology into infusion pumps for improving its delivery system to the patients surges its future demand in the market
Market is also witnessing requirements for customized infusion pumps based on different requirements and treatment protocols. In order to meet this demand, manufacturers are building up their capacities by inclusion of latest technologies in their manufacturing processes which can aid them to meet evolving regulatory standards.
These technological advances, taken as a whole, spur market growth by meeting increasing demands from healthcare providers for safer, more efficient, and adaptable infusion pump solutions in current medical practice.
Product Recalls and Safety Concerns of Infusion Pumps Constrains their Market Growth
Infusion pumps are critical medical devices that are essentially used to deliver medications and fluids in specific amounts. Intrinsic complexity in the devices can provoke serious harm to patients through mechanical failures, software glitches, or incorrect dosing.
This has been a noisemaker among regulatory bodies, healthcare institutions, and the media in case of product recall. This publicity creates an unreliability perception that makes hospitals and clinics more cautious in their purchasing decisions. It may delay or prevent the adoption of new models for fear of the recurrence of such problems and disruption of care to the patients, not mentioning the additional cost of replacing or repairing devices.
It also brings about calls for stricter regulatory control, which may further delay new model approvals and hinder the launch of new technologies. Tighter scrutiny on manufacturers might require higher investments in research, development, and post-marketing surveillance to ensure compliance of products with prescribed safety standards. This does not only increase costs but will also affect overall market growth.
Furthermore, multiple recalls will also hurt a company's credibility and make it hard to compete with other manufacturers.
Increasing Demand for Home Infusion Therapy Owing to its Added Advantages
Home infusion treatment allows for the intravenous administration of medications and fluids in the comfort of a patient's home. The increase in trend of outpatient care and home-based treatments essentially serves the purpose of reducing health care expenditure.
In addition to reducing hospital stays, this will minimize the occurrence of nosocomial infections and greatly enhance the comfort and convenience of patients. And as more and more health care providers and payers have come to this realization, the demand for home infusion therapy has increased phenomenally.
The aged population, and the increase in chronic diseases diabetes, cancer, heart failure, among others all require long-term medication management, frequent dosing are better handled through home infusion therapy. Infusion pumps, especially portable ones with easy use, become critical in the delivery of such treatments safely and accurately at home.
Advancements in technology have also irrevocably made modern infusion pumps more compact, easier to use, and capable of remote monitoring, features highly relevant for home care settings where patients or caregivers may not possess the same degree of medical training as that found in a hospital setting.
This ability to manage therapy remotely will also attract healthcare providers for the sake of keeping continuous monitoring over patients for timely intervention in case of emergencies.
In general, the growth of home infusion therapy will definitely support the sales of infusion pumps, since their use expands beyond traditional healthcare facilities to give solutions with growing demand for home-based care.
The global infusion pump cover industry recorded a CAGR of 4.6% during the historical period between 2019 and 2023. The growth of infusion pump cover industry was positive as it reached a value of USD 4,688.2 million in 2023 from 3,750.6 million in 2019.
Advancement in medical technology has significantly improved the infusion pump market as they are able to address the growing need of precision medication along with the rising prevalence of chronic diseases. Moreover, regulatory standards implemented by regulatory authorities for assuring patient safety, has majorly contributed to its increasing adoption.
The market has also witnessed a significant growth owing to the preferential shift of patients towards home healthcare, which is more convenient rather staying confined to the hospital. It also helps in saving healthcare costs through improved efficiency and reduced hospitalization.
Several factors such as rising prevalence of chronic diseases including diabetes, cancer, and immune disorders are projected to continue the growth of infusion pumps in the near future as it is essential to provide accurate and continuous medication therapies to these patients. Improvements in the design of infusion pumps for safety and accuracy, with wireless connectivity to digital health systems, further augment their growing demand in different healthcare settings.
Further, the growing trend toward home care solutions is likely to boost the demand for portable, user-friendly infusion pumps used outside the traditional hospital setting. Moreover, the support extended by healthcare authorities for the development of healthcare infrastructure in emerging markets also contributes to increase in adoption rate of infusion pump technologies.
Tier 1 companies comprise market leaders with a market revenue of above USD 100 million capturing significant market share of 15% to 20% in global market. These market leaders are characterized by high production capacity, wide product portfolio, and range of services in the market.
These market leaders are differentiating themselves from the market based on the technology, extensive expertise in manufacturing and broad geographical outreach reach in the market. These factors have aided them in serving a wide range of consumer base. Prominent companies within tier 1 include Medtronic Plc., B. Braun Melsungen AG, Baxter International Inc., and Terumo Corporation.
Tier 2 companies include mid-size players with revenue of USD 50 to 100 million having presence in specific regions with their high influence on the local market. These players are characterized by their strong market knowledge. These market players have good technology and ensure regulatory compliance but may be limited to their availability in certain markets. Prominent companies in tier 2 include Fresenius Kabi AG, Smiths Medical, MOOG Inc., and ICU Medical, Inc.
Tier 3 includes the majority of companies that have limited geographical outreach or are operating at the local presence. These companies are focused towards fulfilling the demand of local market and are therefore classified as the tier 3 share segment. They are comparatively small-scale players and are recognized as an unorganized market, which doesn’t have developed infrastructure structure and higher production capabilities.
The section below covers the industry analysis for the infusion pump cover market for different countries. Market demand analysis on key countries in several regions of the globe, including North America, Asia Pacific, Europe, and others, is provided. The United States is anticipated to remain at the forefront in North America, and is projected to grow at a CAGR of 4.8% through 2034. In Asia Pacific, India is projected to witness a CAGR of 9.4% by 2034.
| Countries | Value CAGR (2024 to 2034) |
|---|---|
| Canada | 5.3% |
| Spain | 2.5% |
| France | 4.6% |
| South Korea | 7.9% |
| China | 12.3% |
| Australia | 6.7% |
Germany’s infusion pump cover market is poised to exhibit a CAGR of 2.9% between 2024 and 2034. The growth in infusion pumps in Germany are largely contributed by the increasing healthcare expenditure, increasing aging population, rise in prevalence of chronic diseases, and improvement in technology for pumps.
The pump technology allows for safe and accurate medication administration, which is really very essential for managing complex conditions while supporting both hospital and homecare settings. Therefore, the assistance provided by infusion pumps in the efficient delivery of the healthcare by improving efficiency of the healthcare significantly contributes to its adoption in the Germany.
In addition, growing innovation in portable and wearable infusion pumps is also witnessing significant demand in the country which is especially designed for patients requiring continuous medication outside the hospital. These advancements benefits patients to manage chronic conditions such as diabetes.
In North America, the USA holds the highest share of the global infusion pump industry. The market in the USA is anticipated to grow at a CAGR of 4.8% throughout the forecast period 2034.
The rising needs of management of chronic diseases in the USA along with the growing geriatric population of the country majorly contributes to the growth of the infusion pumps. In addition to this, the precision offered by these pumps in the delivery of medications and the preferential shift of patients towards healthcare at home, are few of the other factors augmenting the growth of the infusion pumps in the market.
These infusion pumps not only facilitates smoother healthcare workflows, but they also help raise the accuracy of treatments to a considerable degree, with their integration. Therefore, significantly improved patient outcomes with the whole efficiency of healthcare delivery further contributes to the growth of the market in the United States.
The factors that would continue to drive the growth of infusion pumps in China include rising healthcare expenditure, growing aging population with associated increased healthcare needs, and a rise in chronic diseases.
In addition to this growing investment in the development of healthcare infrastructure in the country, and the initiatives taken by government for improving the accessibility of quality care in order to improve patient outcomes further surges the market growth.
These growing healthcare infrastructure has brought business opportunities for new entrants. Therefore, the growing number of local players focusing towards strengthening their market presence by supplying their products to the domestic market along with their efforts towards export of their products in the international market further expands the growth of the infusion pumps in China.
The section contains information about the leading segments in the industry. By product, the volumetric pumps segment is estimated to account for 22.0% of the market share and is anticipated to witness significant growth during the forecast period.
| Product | Volumetric Pumps |
|---|---|
| Value Share (2034) | 22.0% |
The volumetric pumps segment is projected to dominate the market in terms of revenue, and account for almost 22% of the market share in 2034. The segment holds highest share owing to its precision in the delivery of fluids and medications. Their crucial role in managing complex treatments, their ability to minimize medication errors, and their flexibility to adopt varied flow has contributed to their increased adoption in the high-stakes medical situations.
In addition to this, the inclusion of advanced features such as programmable infusion rates, real-time monitoring and alarms for occlusions and air bubbles make them one of the preferred choice among healthcare professionals and healthcare facility providers.
Moreover, their reliability in maintaining the constant infusion rates for extended period of time ensuring patient safety and treatment efficacy in patients undergoing oncology and other treatments significantly contributed to the segment growth.
| Application | Gastroenterology |
|---|---|
| Value Share (2034) | 24.9% |
The gastroenterology segment is forecasted to account for a revenue share of over 24.9% in the infusion pump cover market by 2034 end. Factors that are favoring the growth of the gastroenterology segment is its rising prevalence among young and adult population. Administration of infusion pump is crucial for the management of person suffering from gastrointestinal disease as they often face issues with hydration and electrolyte balance.
Infusion pumps aid in management of the condition by providing precise fluid and electrolyte to the patient. They also help healthcare professionals to manage patients suffering from chronic pain, and the patients undergoing chemotherapy for gastrointestinal cancer. Moreover, the technological advancements in the infusion pumps that have capability to meet the complex treatment needs of gastroenterology disorders further augments the segment growth.
Key players operating in the infusion pump cover market are investing in development of advanced and innovative products that are more reliable and efficient. Also, many of the key players are emphasizing on launching new products to the market for expansion of their product portfolio and strengthening their market share.
Recent Industry Developments in Infusion Pumps Market
The global infusion pump cover industry is projected to witness CAGR of 5.4% between 2024 and 2034.
The global infusion pump cover industry stood at USD 4,932.2 million in 2024.
The global infusion pump cover industry is anticipated to reach USD 8,345.4 million by 2034 end.
China is set to record the highest CAGR of 12.3% in the assessment period.
The key players operating in the global infusion pump cover industry include Medtronic Plc, B. Braun Melsungen AG, Fresenius Kabi AG, Baxter International Inc., ICU Medical, Inc., are few of the key players in the infusion pump cover industry.
In terms of product type, the industry is divided into syringe pumps, small volume pump, ambulatory pumps, volumetric pumps, peristaltic, cassette/piston, implantable pumps, insulin pumps, enteral pumps, PCA pumps, and pump accessories.
In terms of modality, the industry is divided into stationary pumps and infusion pumps.
In terms of application, the industry is segregated into chemotherapy/oncology, pediatrics/neonatology, analgesia, gastroenterology, hematology and diabetes.
In terms of end user, the industry is segregated into hospitals, ambulatory surgical centers, home care, clinics and others.
Key countries of North America, Latin America, Eastern Europe, Western Europe, East Asia, South Asia & Pacific, and Middle East and Africa (MEA), have been covered in the report.
Infusion Pumps Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
